MoonLake Immunotherapeutics

MLTX • NASDAQ •
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $0 $19 $0 $0
Gross Profit -22 16 -3 -3
EBITDA -19,797 -15,025 -12,973 -13,182
EBIT -19,820 -15,028 -12,976 -13,185
Net Income -13,673 -7,437 -9,426 -10,139
Net Change In Cash 0 19 0 0
Cost of Revenue 451,802
Free Cash Flow -15,160 -12,628 -9,250 -12,158
Cash 458,441 451,169 318,165 501,786
Basic Shares 62,637 59,914 53,517 43,718

Annual Financials

Values in thousands 2023-12-31 2022-12-31
Revenue $0 $0
Gross Profit -13 -12
EBITDA -54,109 -65,049
EBIT -54,123 -65,061
Net Income -36,007 -64,506
Net Change In Cash 0 0
Cost of Revenue 31,458
Free Cash Flow -43,062 -55,909
Cash 451,169 39,505
Basic Shares 49,122 29,361

Earnings Calls

Quarter EPS
2024-03-31 -$0.22
2023-12-31 -$0.12
2023-09-30 -$0.18
2023-06-30 -$0.23